[ORGANIZATION]
Alexion
Featured in 3 tracked stories · first seen
Situations
FDA priority reviews for new medical therapies
2 clusters · 5 sources · last updated
Latest: Roche's fenebrutinib receives FDA priority review for multiple sclerosis
The U.S. Food and Drug Administration (FDA) has granted priority review to several new investigational therapies for various medical conditions. In late September 2026, the FDA granted priority review to Bayer’s elinzan
Also covered in
-
Alexion and Aide Health launch AI app for rare disease patients
[HEALTH] · 2 sources ·
-
Alexion to conduct 19 registrational studies for rare diseases in Italy
[HEALTH] · 3 sources ·